Abstract
Epigenetics describes the phenomenon of heritable changes in gene regulation that are governed by non-Mendelian processes, primarily through biochemical modifications to chromatin structure that occur during cell development and differentiation. Numerous lines of evidence link abnormal levels of chromatin modifications (either to DNA, histones, or both) in patients with a wide variety of diseases including cancer, psychiatry, neurodegeneration, metabolic and inflammatory disorders. Drugs that target the proteins controlling chromatin modifications can modulate the expression of clusters of genes, potentially offering higher therapeutic efficacy than classical agents with single target pharmacologies that are susceptible to biochemical pathway degeneracy. Here, we summarize recent research linking epigenetic dysregulation with diseases in neurosciences, the application of relevant animal models, and the potential for small molecule modulator development to facilitate target discovery, validation and translation into clinical treatments.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- 2-OG:
-
2-Oxo-glutarate
- AAV:
-
Adeno-associated virus
- BDNF:
-
Brain-derived neurotrophic factor
- BET:
-
Bromodomain and extra C-terminal domain protein
- CaMK:
-
Ca2+/calmodulin-dependent protein kinase
- CDK5:
-
Cyclin-dependent kinase 5
- ChIP:
-
Chromatin immunoprecipitation
- CoA:
-
Coenzyme A
- CpG:
-
Short stretches of DNA in which the frequency of C and G base pairs are higher than other regions
- CREB:
-
cAMP response element binding protein
- CRH:
-
Corticotrophin releasing hormone
- CTCL:
-
Cutaneous T-cell lymphoma
- DNMT:
-
DNA methyltransferase
- FAD:
-
Flavin adenine dinucleotide
- FPC:
-
Frontopolar cortex
- FRET:
-
Forster resonance energy transfer
- GABA:
-
Gamma-aminobutyric acid
- GR:
-
Glucocorticoid receptor
- H3K9Me2:
-
Histone H3 dimethylated at lysine-9 ε-nitrogen
- HAT:
-
Histone acetyl transferase
- HDAC:
-
Histone deacetylase
- HSV:
-
Herpes simplex virus
- IKB:
-
IκB transcription factor
- IKK:
-
IκB kinase
- JMJD:
-
Jumonji (demethylase) domain
- KDM:
-
Lysine demethylase
- KO:
-
Knockout
- LG:
-
Licking and grooming
- LSL:
-
Lox P-stop-Lox P cassette
- LTP:
-
Long-term potentiation
- MAOI:
-
Monoamine oxidase inhibitor
- MBD:
-
Methyl-CpG-binding domain protein
- MBT:
-
Maligant brain tumour domain
- MeCP2:
-
Methyl CpG binding protein 2
- miRNA:
-
MicroRNA
- NAc:
-
Nucleus accumbens
- NFκB:
-
Nuclear factor-kappaB
- NGFIA:
-
Nerve growth factor inducible protein A
- PHD:
-
Plant homeodomain
- PRMT:
-
Arginine methyltransferase
- PTGS:
-
Post-transcriptional gene silencing
- SAHA:
-
Suberoyl-aniline hydroxamic acid
- SirT:
-
Sirtuin (NAD+-dependent histone deacetylase)
- SUMO:
-
Small ubiquitin-like modifier
- TSA:
-
Trichostatin A
- TSS:
-
Transcription start site
- WT:
-
Wild-type
References
Adams-Cioaba MA, Min J (2009) Structure and function of histone methylation binding proteins. Biochem Cell Biol 87(1):93–105
Adcock IM (2007) HDAC inhibitors as anti-inflammatory agents. Br J Pharmacol 150(7):829–831
Ahmed SH, Koob GF (1997) Cocaine- but not food-seeking behavior is reinstated by stress after extinction. Psychopharmacology (Berl) 132(3):289–295
Alexander VM, Roy M et al (2010) Azacytidine induces cell cycle arrest and suppression of neuroendocrine markers in carcinoids. Int J Clin Exp Med 3(2):95–102
Amir RE, Van den Veyver IB et al (1999) Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 23(2):185–188
Bannister AJ, Kouzarides T (2005) Reversing histone methylation. Nature 436(7054):1103–1106
Bannister AJ, Zegerman P et al (2001) Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain. Nature 410(6824):120–124
Barrot M, Olivier JD et al (2002) CREB activity in the nucleus accumbens shell controls gating of behavioral responses to emotional stimuli. Proc Natl Acad Sci USA 99(17):11435–11440
Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116(2):281–297
Bartel DP, Chen CZ (2004) Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs. Nat Rev Genet 5(5):396–400
Berton O, McClung CA et al (2006) Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science 311(5762):864–868
Biswas SK, Lewis CE (2010) NF-{kappa}B as a central regulator of macrophage function in tumors. J Leukoc Biol 88(5):877–884
Blackledge NP, Klose R (2010) Histone lysine methylation: an epigenetic modification? Epigenomics 2(1):151–161
Borrelli E, Nestler EJ et al (2008) Decoding the epigenetic language of neuronal plasticity. Neuron 60(6):961–974
Bradner JE, West N et al (2009) Chemical phylogenetics of histone deacetylases. Nat Chem Biol 6(3):238–243
Brami-Cherrier K, Roze E et al (2009) Role of the ERK/MSK1 signalling pathway in chromatin remodelling and brain responses to drugs of abuse. J Neurochem 108(6):1323–1335
Brown P, Hunger SP et al (2009) Novel targeted drug therapies for the treatment of childhood acute leukemia. Expert Rev Hematol 2(9):145
Budden SS, Dorsey HC et al (2005) Clinical profile of a male with Rett syndrome. Brain Dev 27(Suppl 1):S69–S71
Carlezon WA Jr, Thome J et al (1998) Regulation of cocaine reward by CREB. Science 282(5397):2272–2275
Carney RM, Wolpert CM et al (2003) Identification of MeCP2 mutations in a series of females with autistic disorder. Pediatr Neurol 28(3):205–211
Cavalleri GL, Walley NM et al (2007) A multicenter study of BRD2 as a risk factor for juvenile myoclonic epilepsy. Epilepsia 48(4):706–712
Champagne DL, Bagot RC et al (2008) Maternal care and hippocampal plasticity: evidence for experience-dependent structural plasticity, altered synaptic functioning, and differential responsiveness to glucocorticoids and stress. J Neurosci 28(23):6037–6045
Chen RZ, Akbarian S et al (2001) Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat Genet 27(3):327–331
Chen GG, Chak EC et al (2003a) Glioma apoptosis induced by macrophages involves both death receptor-dependent and independent pathways. J Lab Clin Med 141(3):190–199
Chen WG, Chang Q et al (2003b) Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science 302(5646):885–889
Collins AL, Levenson JM et al (2004) Mild overexpression of MeCP2 causes a progressive neurological disorder in mice. Hum Mol Genet 13(21):2679–2689
Collins RE, Northrop JP et al (2008) The ankyrin repeats of G9a and GLP histone methyltransferases are mono- and dimethyllysine binding modules. Nat Struct Mol Biol 15(3):245–250
Covington HE 3rd, Maze I et al (2009) Antidepressant actions of histone deacetylase inhibitors. J Neurosci 29(37):11451–11460
Culhane JC, Wang D et al (2010) Comparative analysis of small molecules and histone substrate analogues as LSD1 lysine demethylase inhibitors. J Am Chem Soc 132(9):3164–3176
Dashwood RH, Ho E (2007) Dietary histone deacetylase inhibitors: from cells to mice to man. Semin Cancer Biol 17(5):363–369
Davis CD, Uthus EO (2004) DNA methylation, cancer susceptibility, and nutrient interactions. Exp Biol Med (Maywood) 229(10):988–995
Dayer AG, Bottani A et al (2007) MECP2 mutant allele in a boy with Rett syndrome and his unaffected heterozygous mother. Brain Dev 29(1):47–50
Dhalluin C, Carlson JE et al (1999) Structure and ligand of a histone acetyltransferase bromodomain. Nature 399(6735):491–496
Dong E, Agis-Balboa RC et al (2005) Reelin and glutamic acid decarboxylase67 promoter remodeling in an epigenetic methionine-induced mouse model of schizophrenia. Proc Natl Acad Sci USA 102(35):12578–12583
Dong J, Jimi E et al (2010) Constitutively active NF-kappaB triggers systemic TNFalpha-dependent inflammation and localized TNFalpha-independent inflammatory disease. Genes Dev 24(16):1709–1717
Edwards AM, Bountra C et al (2009) Open access chemical and clinical probes to support drug discovery. Nat Chem Biol 5(7):436–440
Erb S, Shaham Y et al (1996) Stress reinstates cocaine-seeking behavior after prolonged extinction and a drug-free period. Psychopharmacology (Berl) 128(4):408–412
Escoubet-Lozach L, Lin IL et al (2009) Pomalidomide and lenalidomide induce p21 WAF-1 expression in both lymphoma and multiple myeloma through a LSD1-mediated epigenetic mechanism. Cancer Res 69(18):7347–7356
Fan G, Hutnick L (2005) Methyl-CpG binding proteins in the nervous system. Cell Res 15(4):255–261
Feng J, Sun G et al (2009) Evidence for X-chromosomal schizophrenia associated with microRNA alterations. PLoS One 4(7):e6121
Ferraris DV (2010) Evolution of poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors. From concept to clinic. J Med Chem 53(12):4561–4584
Florence B, Faller DV (2001) You bet-cha: a novel family of transcriptional regulators. Front Biosci 6:D1008–D1018
Fog CK, Jensen KT et al (2007) Chromatin-modifying proteins in cancer. APMIS 115(10):1060–1089
Francis D, Diorio J et al (1999) Nongenomic transmission across generations of maternal behavior and stress responses in the rat. Science 286(5442):1155–1158
Fuks F, Hurd PJ et al (2003) The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation. J Biol Chem 278(6):4035–4040
Giacometti E, Luikenhuis S et al (2007) Partial rescue of MeCP2 deficiency by postnatal activation of MeCP2. Proc Natl Acad Sci USA 104(6):1931–1936
Goll MG, Bestor TH (2005) Eukaryotic cytosine methyltransferases. Annu Rev Biochem 74:481–514
Grayson DR, Kundakovic M et al (2008) Is there a future for histone deacetylase inhibitors in the pharmacotherapy of psychiatric disorders? Mol Pharmacol 77(2):126–135
Green TA, Alibhai IN et al (2006) Induction of inducible cAMP early repressor expression in nucleus accumbens by stress or amphetamine increases behavioral responses to emotional stimuli. J Neurosci 26(32):8235–8242
Greiner D, Bonaldi T et al (2005) Identification of a specific inhibitor of the histone methyltransferase SU(VAR)3-9. Nat Chem Biol 1(3):143–145
Grozinger CM, Chao ED et al (2001) Identification of a class of small molecule inhibitors of the sirtuin family of NAD-dependent deacetylases by phenotypic screening. J Biol Chem 276(42):38837–38843
Guan JS, Haggarty SJ et al (2009) HDAC2 negatively regulates memory formation and synaptic plasticity. Nature 459(7243):55–60
Guy J, Hendrich B et al (2001) A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat Genet 27(3):322–326
Guy J, Gan J et al (2007) Reversal of neurological defects in a mouse model of Rett syndrome. Science 315(5815):1143–1147
Hahnen E, Hauke J et al (2008) Histone deacetylase inhibitors: possible implications for neurodegenerative disorders. Expert Opin Investig Drugs 17(2):169–184
Hammond SM, Caudy AA et al (2001) Post-transcriptional gene silencing by double-stranded RNA. Nat Rev Genet 2(2):110–119
Hassa PO, Haenni SS et al (2006) Nuclear ADP-ribosylation reactions in mammalian cells: where are we today and where are we going? Microbiol Mol Biol Rev 70(3):789–829
Hassan YI, Zempleni J (2008) A novel, enigmatic histone modification: biotinylation of histones by holocarboxylase synthetase. Nutr Rev 66(12):721–725
Healy S, Heightman TD et al (2009) Nonenzymatic biotinylation of histone H2A. Protein Sci 18(2):314–328
Heidbreder C (2011) Advances in animal models of drug addiction. Springer, Heidelberg. doi:10.1007/7854_2010_107
Heltweg B, Gatbonton T et al (2006) Antitumor activity of a small-molecule inhibitor of human silent information regulator 2 enzymes. Cancer Res 66(8):4368–4377
Hooker J, Kim SW et al (2010) Histone deacetylase inhibitor MS-275 exhibits poor brain penetration: pharmacokinetic studies of [11C]MS-275 using positron emission tomography. ACS Chem Neurosci 1(1):65–73
Hrzenjak A, Moinfar F et al (2010) Histone deacetylase inhibitor vorinostat suppresses the growth of uterine sarcomas in vitro and in vivo. Mol Cancer 9:49
Huang B, Yang XD et al (2009) Brd4 coactivates transcriptional activation of NF-kappaB via specific binding to acetylated RelA. Mol Cell Biol 29(5):1375–1387
Huang Y, Pastor WA et al (2010) The behaviour of 5-hydroxymethylcytosine in bisulfite sequencing. PLoS One 5(1):e8888
Hyman SE, Malenka RC et al (2006) Neural mechanisms of addiction: the role of reward-related learning and memory. Annu Rev Neurosci 29:565–598
Jaenisch R, Bird A (2003) Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 33(Suppl):245–254
Jan MM, Dooley JM et al (1999) Male Rett syndrome variant: application of diagnostic criteria. Pediatr Neurol 20(3):238–240
Jenuwein T, Allis CD (2001) Translating the histone code. Science 293(5532):1074–1080
Kim IA, Kim IH et al (2010) HDAC inhibitor-mediated radiosensitization in human carcinoma cells: a general phenomenon? J Radiat Res (Tokyo) 51(3):257–263
Klauck SM, Lindsay S et al (2002) A mutation hot spot for nonspecific X-linked mental retardation in the MECP2 gene causes the PPM-X syndrome. Am J Hum Genet 70(4):1034–1037
Klose RJ, Bird AP (2006) Genomic DNA methylation: the mark and its mediators. Trends Biochem Sci 31(2):89–97
Koob G, Kreek MJ (2007) Stress, dysregulation of drug reward pathways, and the transition to drug dependence. Am J Psychiatry 164(8):1149–1159
Kouzarides T (2007) Chromatin modifications and their function. Cell 128(4):693–705
Kovacheva VP, Mellott TJ et al (2007) Gestational choline deficiency causes global and Igf2 gene DNA hypermethylation by up-regulation of Dnmt1 expression. J Biol Chem 282(43):31777–31788
Kriaucionis S, Bird A (2003) DNA methylation and Rett syndrome. Hum Mol Genet 12 Spec No 2:R221–R227
Kriaucionis S, Heintz N (2009) The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science 324(5929):929–930
Kubicek S, O’Sullivan RJ et al (2007) Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferase. Mol Cell 25(3):473–481
Kumar A, Choi KH et al (2005) Chromatin remodeling is a key mechanism underlying cocaine-induced plasticity in striatum. Neuron 48(2):303–314
Lachner M, O’Carroll D et al (2001) Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature 410(6824):116–120
Lam CW, Yeung WL et al (2000) Spectrum of mutations in the MECP2 gene in patients with infantile autism and Rett syndrome. J Med Genet 37(12):E41
Langereis JD, Raaijmakers HA et al (2010) Abrogation of NF-{kappa}B signaling in human neutrophils induces neutrophil survival through sustained p38-MAPK activation. J Leukoc Biol 88:655–664
Lau OD, Kundu TK et al (2000) HATs off: selective synthetic inhibitors of the histone acetyltransferases p300 and PCAF. Mol Cell 5(3):589–595
Lee MG, Wynder C et al (2006) Histone H3 lysine 4 demethylation is a target of nonselective antidepressive medications. Chem Biol 13(6):563–567
Lee JH, Choy ML et al (2010) Histone deacetylase inhibitor induces DNA damage, which normal but not transformed cells can repair. Proc Natl Acad Sci USA 107(33):14639–14644
Levenson JM, Sweatt JD (2005) Epigenetic mechanisms in memory formation. Nat Rev Neurosci 6(2):108–118
Li X, Chen BD (2009) Histone deacetylase inhibitor M344 inhibits cell proliferation and induces apoptosis in human THP-1 leukemia cells. Am J Biomed Sci 1(4):352–363
Li E, Bestor TH et al (1992) Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69(6):915–926
Lister R, Pelizzola M et al (2009) Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 462(7271):315–322
Liu D, Diorio J et al (1997) Maternal care, hippocampal glucocorticoid receptors, and hypothalamic-pituitary-adrenal responses to stress. Science 277(5332):1659–1662
Liu F, Chen X et al (2009) Discovery of a 2, 4-diamino-7-aminoalkoxyquinazoline as a potent and selective inhibitor of histone lysine methyltransferase G9a. J Med Chem 52(24):7950–7953
Loenarz C, Schofield CJ (2009) Oxygenase catalyzed 5-methylcytosine hydroxylation. Chem Biol 16(6):580–583
Luthi-Carter R, Taylor DM et al (2010) SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis. Proc Natl Acad Sci USA 107(17):7927–7932
Ma X, Ezzeldin HH et al (2009) Histone deacetylase inhibitors: current status and overview of recent clinical trials. Drugs 69(14):1911–1934
Maiwald R, Bonte A et al (2002) De novo MECP2 mutation in a 46, XX male patient with Rett syndrome. Neurogenetics 4(2):107–108
Mantelingu K, Reddy BA et al (2007) Specific inhibition of p300-HAT alters global gene expression and represses HIV replication. Chem Biol 14(6):645–657
Manzo F, Tambaro FP et al (2009) Histone acetyltransferase inhibitors and preclinical studies. Expert Opin Ther Pat 19(6):761–774
Masuyama T, Matsuo M et al (2005) Classic Rett syndrome in a boy with R133C mutation of MECP2. Brain Dev 27(6):439–442
Maze I, Covington HE 3rd et al (2010) Essential role of the histone methyltransferase G9a in cocaine-induced plasticity. Science 327(5962):213–216
McGill BE, Bundle SF et al (2006) Enhanced anxiety and stress-induced corticosterone release are associated with increased Crh expression in a mouse model of Rett syndrome. Proc Natl Acad Sci USA 103(48):18267–18272
McGowan PO, Kato T (2008) Epigenetics in mood disorders. Environ Health Prev Med 13(1):16–24
McGowan PO, Meaney MJ et al (2008) Diet and the epigenetic (re)programming of phenotypic differences in behavior. Brain Res 1237:12–24
McGowan PO, Sasaki A et al (2009) Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat Neurosci 12(3):342–348
Merali Z, Du L et al (2004) Dysregulation in the suicide brain: mRNA expression of corticotropin-releasing hormone receptors and GABA(A) receptor subunits in frontal cortical brain region. J Neurosci 24(6):1478–1485
Metzger E, Wissmann M et al (2005) LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription. Nature 437(7057):436–439
Metzger E, Yin N et al (2008) Phosphorylation of histone H3 at threonine 11 establishes a novel chromatin mark for transcriptional regulation. Nat Cell Biol 10(1):53
Milani D, Pantaleoni C et al (2005) Another patient with MECP2 mutation without classic Rett syndrome phenotype. Pediatr Neurol 32(5):355–357
Minsky N, Shema E et al (2008) Monoubiquitinated H2B is associated with the transcribed region of highly expressed genes in human cells. Nat Cell Biol 10(4):483–488
Mitsubishi/Tanabe (Int. Pat. Appl. WO09/084693)
Moretti P, Bouwknecht JA et al (2005) Abnormalities of social interactions and home-cage behavior in a mouse model of Rett syndrome. Hum Mol Genet 14(2):205–220
Need AC, Ge D et al (2009) A genome-wide investigation of SNPs and CNVs in schizophrenia. PLoS Genet 5(2):e1000373
Ng HH, Bird A (1999) DNA methylation and chromatin modification. Curr Opin Genet Dev 9(2):158–163
Ng SS, Kavanagh KL et al (2007) Crystal structures of histone demethylase JMJD2A reveal basis for substrate specificity. Nature 448(7149):87
Niculescu MD, Craciunescu CN et al (2006) Dietary choline deficiency alters global and gene-specific DNA methylation in the developing hippocampus of mouse fetal brains. FASEB J 20(1):43–49
Nuber UA, Kriaucionis S et al (2005) Up-regulation of glucocorticoid-regulated genes in a mouse model of Rett syndrome. Hum Mol Genet 14(15):2247–2256
Outeiro TF, Kontopoulos E et al (2007) Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson’s disease. Science 317(5837):516–519
Pacholec M, Bleasdale JE et al (2010) SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1. J Biol Chem 285(11):8340–8351
Pagans S, Pedal A et al (2005) SIRT1 regulates HIV transcription via Tat deacetylation. PLoS Biol 3(2):e41
Palmieri D, Lockman PR et al (2009) Vorinostat inhibits brain metastatic colonization in a model of triple-negative breast cancer and induces DNA double-strand breaks. Clin Cancer Res 15(19):6148–6157
Paris M, Porcelloni M et al (2008) Histone deacetylase inhibitors: from bench to clinic. J Med Chem 51(6):1505
Penn NW, Suwalski R et al (1972) The presence of 5-hydroxymethylcytosine in animal deoxyribonucleic acid. Biochem J 126(4):781–790
Perez Fidalgo JA, Roda D et al (2009) Aurora kinase inhibitors: a new class of drugs targeting the regulatory mitotic system. Clin Transl Oncol 11(12):787
Petronis A (2010) Epigenetics as a unifying principle in the aetiology of complex traits and diseases. Nature 465(7299):721–727
Pogribny IP, Ross SA et al (2006) Irreversible global DNA hypomethylation as a key step in hepatocarcinogenesis induced by dietary methyl deficiency. Mutat Res 593(1–2):80–87
Poulter MO, Du L et al (2008) GABAA receptor promoter hypermethylation in suicide brain: implications for the involvement of epigenetic processes. Biol Psychiatry 64(8):645–652
Quinn AM, Bedford MT et al (2009) A homogeneous method for investigation of methylation-dependent protein–protein interactions in epigenetics. Nucleic Acids Res 38(2):e11
Renthal W, Maze I et al (2007) Histone deacetylase 5 epigenetically controls behavioral adaptations to chronic emotional stimuli. Neuron 56(3):517–529
Renthal W, Carle TL et al (2008) Delta FosB mediates epigenetic desensitization of the c-fos gene after chronic amphetamine exposure. J Neurosci 28(29):7344–7349
Renthal W, Kumar A et al (2009) Genome-wide analysis of chromatin regulation by cocaine reveals a role for sirtuins. Neuron 62(3):335–348
Robinson TE, Kolb B (2004) Structural plasticity associated with exposure to drugs of abuse. Neuropharmacology 47(Suppl 1):33–46
Rose NR, Ng SS et al (2008) Inhibitor scaffolds for 2-oxoglutarate-dependent histone lysine demethylases. J Med Chem 51(22):7053–7056
Rose NR, Woon EC et al (2010) Selective inhibitors of the JMJD2 histone demethylases: combined nondenaturing mass spectrometric screening and crystallographic approaches. J Med Chem 53(4):1810–1818
Ross SA (2003) Diet and DNA methylation interactions in cancer prevention. Ann N Y Acad Sci 983:197–207
Ross SA, Milner JA (2007) Epigenetic modulation and cancer: effect of metabolic syndrome? Am J Clin Nutr 86(3):s872–s877
Russo SJ, Mazei-Robison MS et al (2009) Neurotrophic factors and structural plasticity in addiction. Neuropharmacology 56(Suppl 1):73–82
Sachchidanand, Resnick-Silverman L et al (2006) Target structure-based discovery of small molecules that block human p53 and CREB binding protein association. Chem Biol 13(1):81–90
Sakurai M, Rose NR et al (2010) A miniaturized screen for inhibitors of Jumonji histone demethylases. Mol Biosyst 6(2):357–364
Schroeder FA, Lin CL et al (2007) Antidepressant-like effects of the histone deacetylase inhibitor, sodium butyrate, in the mouse. Biol Psychiatry 62(1):55–64
Shahbazian M, Young J et al (2002) Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3. Neuron 35(2):243–254
Shiio Y, Eisenman RN (2003) Histone sumoylation is associated with transcriptional repression. Proc Natl Acad Sci USA 100(23):13225
Sleutels F, Zwart R et al (2002) The non-coding air RNA is required for silencing autosomal imprinted genes. Nature 415(6873):810–813
Slyshenkov VS, Shevalye AA et al (2002) Protective role of l-methionine against free radical damage of rat brain synaptosomes. Acta Biochim Pol 49(4):907–916
Smiraglia DJ, Rush LJ et al (2001) Excessive CpG island hypermethylation in cancer cell lines versus primary human malignancies. Hum Mol Genet 10(13):1413–1419
Stimson L, Rowlands MG et al (2005) Isothiazolones as inhibitors of PCAF and p300 histone acetyltransferase activity. Mol Cancer Ther 4(10):1521–1532
Stipanovich A, Valjent E et al (2008) A phosphatase cascade by which rewarding stimuli control nucleosomal response. Nature 453(7197):879–884
Strahl BD, Allis CD (2000) The language of covalent histone modifications. Nature 403(6765):41–45
Suganuma T, Workman JL (2008) Crosstalk among histone modifications. Cell 135(4):604–607
Swinney DC, Xu YZ et al (2002) A small molecule ubiquitination inhibitor blocks NF-kappa B-dependent cytokine expression in cells and rats. J Biol Chem 277(26):23573
Szyf M (2009) Epigenetics, DNA methylation, and chromatin modifying drugs. Annu Rev Pharmacol Toxicol 49:243–263
Tahiliani M, Koh KP et al (2009) Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324(5929):930–935
Takai N, Narahara H (2010) Histone deacetylase inhibitor therapy in epithelial ovarian cancer. J Oncol 2010:458431
Tan J, Cang S et al (2010) Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents. J Hematol Oncol 3:5
Taverna SD, Li H et al (2007) How chromatin-binding modules interpret histone modifications: lessons from professional pocket pickers. Nat Struct Mol Biol 14(11):1025–1040
Tremolizzo L, Carboni G et al (2002) An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability. Proc Natl Acad Sci USA 99(26):17095–17100
Tremolizzo L, Doueiri MS et al (2005) Valproate corrects the schizophrenia-like epigenetic behavioral modifications induced by methionine in mice. Biol Psychiatry 57(5):500–509
Tsankova NM, Berton O et al (2006) Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat Neurosci 9(4):519–525
Tsankova N, Renthal W et al (2007) Epigenetic regulation in psychiatric disorders. Nat Rev Neurosci 8(5):355–367
Tueting P, Doueiri MS et al (2006) Reelin down-regulation in mice and psychosis endophenotypes. Neurosci Biobehav Rev 30(8):1065–1077
Van den Veyver IB (2002) Genetic effects of methylation diets. Annu Rev Nutr 22:255–282
Voso MT, Santini V et al (2009) Valproic acid at therapeutic plasma levels may increase 5-azacytidine efficacy in higher risk myelodysplastic syndromes. Clin Cancer Res 15(15):5002–5007
Waddington CH (1957) The strategy of the Genes: a Discussion of Some Aspects of Theoretical Biology. Allen and Unwin, London
Wang H, Dymock BW (2009) New patented histone deacetylase inhibitors. Expert Opin Ther Pat 19(12):1727–1757
Watson P, Black G et al (2001) Angelman syndrome phenotype associated with mutations in MECP2, a gene encoding a methyl CpG binding protein. J Med Genet 38(4):224–228
Weaver IC, Cervoni N et al (2004) Epigenetic programming by maternal behavior. Nat Neurosci 7(8):847–854
Weaver IC, Champagne FA et al (2005) Reversal of maternal programming of stress responses in adult offspring through methyl supplementation: altering epigenetic marking later in life. J Neurosci 25(47):11045–11054
Weaver IC, Meaney MJ et al (2006) Maternal care effects on the hippocampal transcriptome and anxiety-mediated behaviors in the offspring that are reversible in adulthood. Proc Natl Acad Sci USA 103(9):3480–3485
Wigle TJ, Herold JM et al (2010) Screening for inhibitors of low-affinity epigenetic peptide–protein interactions: an AlphaScreen-based assay for antagonists of methyl-lysine binding proteins. J Biomol Screen 15(1):62–71
Wyatt A, Benedict RG, Davis J (1971) Biochemical and sleep studies of schizophrenia: a review of the literature – 1960–1970. Schizophr Bull 4:10–44
Yang M, Culhane JC et al (2007) Structural basis for the inhibition of the LSD1 histone demethylase by the antidepressant trans-2-phenylcyclopropylamine. Biochemistry 46(27):8058–8065
Yoshida M, Kijima M et al (1990) Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J Biol Chem 265(28):17174–17179
Zhou Z, Hong EJ et al (2006) Brain-specific phosphorylation of MeCP2 regulates activity-dependent Bdnf transcription, dendritic growth, and spine maturation. Neuron 52(2):255–269
Zhu X, Ma Y et al (2010) Novel agents and regimens for acute myeloid leukemia: 2009 ASH annual meeting highlights. J Hematol Oncol 3:17
Zippo A, Serafini R et al (2009) Histone crosstalk between H3S10ph and H4K16ac generates a histone code that mediates transcription elongation. Cell 138(6):1122
Acknowledgments
The Structural Genomics Consortium (a registered charity; number 1097737) receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck and Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research and the Wellcome Trust. The work was supported by the NIHR Biomedical Research Unit Oxford. We gratefully acknowledge the assistance of Ms J. Zapisek and Ms. M. Kalinowska in the preparation of this article.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Bountra, C., Oppermann, U., Heightman, T.D. (2011). Animal Models of Epigenetic Regulation in Neuropsychiatric Disorders. In: Hagan, J. (eds) Molecular and Functional Models in Neuropsychiatry. Current Topics in Behavioral Neurosciences, vol 7. Springer, Berlin, Heidelberg. https://doi.org/10.1007/7854_2010_104
Download citation
DOI: https://doi.org/10.1007/7854_2010_104
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-19702-4
Online ISBN: 978-3-642-19703-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)